Christiane Pott

Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation.

T. Müller, B. Metzner, D. Kraemer, 2013, Annals of Oncology.

Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a pros

C. Pott, M. Dreyling, F. Hartmann, 2006, Blood.

Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting

G. Lenz, C. Buske, C. Pott, 2012, Annals of Hematology.

Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a pros

W. Hiddemann, M. Qumsiyeh, H. Einsele, 2006, Blood.

Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial.

E. Hoster, P. Feugier, H. Tilly, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study.

E. Hoster, N. Spielewoy, M. Unterhalt, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up.

N. Schmitz, A. Ho, S. Dietrich, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Genomic and epigenomic co-evolution in follicular lymphomas

M. Rosolowski, M. Szczepanowski, H. Trautmann, 2014, Leukemia.